Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial

Natale Cascinelli, Alberto Morabito(University of Milan), Filiberto Belli(Fondazione IRCCS Istituto Nazionale dei Tumori), Rosaria Bufalino, Mario Santinami(Fondazione IRCCS Istituto Nazionale dei Tumori), Rona M. MacKie(University of Glasgow)
The Lancet
September 1, 2001
10.1016/s0140-6736(01)06068-8
Cited by 251

Related Papers

Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
|New England Journal of Medicine|1996|7.1k
Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma
|New England Journal of Medicine|2017|1.5k
Inefficacy of Immediate Node Dissection in Stage 1 Melanoma of the Limbs
|New England Journal of Medicine|1977|667
Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial
|The Lancet|1998|648
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
|The Lancet|2008|642